SCHEMBL7330908

SCHEMBL7330908

CC(C)[C@H](NC(=O)N(C)Cc1cccnc1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)N(C)Cc1ccccn1)C(C)C

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.86
CYP3A4 P08684 10/20 0.50
LMNA P02545 1/20 0.49
CYP2D6 P10635 5/20 0.47
CYP1A2 P05177 3/20 0.47
CYP2C19 P33261 3/20 0.47
MAPT P10636 2/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP2C9 P11712 3/20 0.43
MEN1 O00255 1/20 0.43
SLC22A2 O15244 1/20 0.43
SLC22A1 O15245 1/20 0.43
ABCC3 O15438 1/20 0.43
ABCC4 O15439 1/20 0.43
MLNR O43193 1/20 0.43
NR1I2 O75469 1/20 0.43
SLCO2B1 O94956 1/20 0.43
ABCB11 O95342 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7341937 0.93 CA2 (0.72) CA2CYP3A4LMNACYP2D6CYP1A2
A-77003 SCHEMBL6448973 0.93 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL7338211 0.93 CA2 (0.72) CA2CYP3A4LMNACYP2D6CYP1A2
A-77003 SCHEMBL2770013 0.93 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
A-77003 SCHEMBL7337518 0.93 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL7334995 0.93 CA2 (0.72) CA2CYP3A4LMNACYP2D6CYP1A2
A-77003 SCHEMBL8749867 0.93 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
A-76928 SCHEMBL6449595 0.93 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL7331974 0.91 CA2 (0.77) CA2CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL7337044 0.91 CA2 (0.77) CA2CYP3A4CYP2D6CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed